Docs Who Lift

Dr. Nicola Guess, an RD and PhD researcher from Oxford, dives into the world of continuous glucose monitors (CGMs) and their implications for those without type 2 diabetes. She discusses the nuances of glucose dynamics and the misconceptions surrounding glucose data interpretations. Nicola emphasizes the importance of understanding individual glucose responses, especially regarding diet and exercise. Plus, she highlights the potential mental health impacts of CGM usage, advocating for a more holistic approach to health rather than fixating solely on glucose levels.

Drs. Karl and Spencer discuss the new SELECT results that show a decrease in cardiovascular events in those taking Wegovy who have a history of cardiovascular disease. See trial below https://www.nejm.org/doi/full/10.1056/NEJMoa2307563

Discussion on the approval and effectiveness of tirzepatide for obesity, its availability and cost, differences compared to Mounjaro, and details about the Surmount 3 trial. Exploration of the limitations of endogenous GLP-1 and GIP production for obesity treatment. Dosing and indications of tirzepatide for glycemic control and weight reduction and the impact of intensive lifestyle therapy. Emphasis on the importance of lifestyle factors in weight loss, including weightlifting, muscle building, and regular strength training.

Dr. Kathleen Keller, researcher studying taste preferences and food choices in kids, discusses brain signaling in relation to obesity. The podcast explores childhood food preferences, brain changes and obesity through functional MRI, challenges and resilience in obesity, repeated exposure to develop food preferences, and the importance of helping people with obesity.

Drs. Karl and Spencer chat about some of the new tirzepatide studies including SURMOUNT-4 from the EASD

Dr. Bassin, a specialist in type 2 diabetes and physical activity, joins Drs. Karl and Spencer to discuss exercise and physical activity for type 2 diabetes. They explore the benefits of walking after meals, various activities to reduce the risk of type 2 diabetes, and the advantages of yoga for physical and mental health.

Drs. Karl and Spencer discuss how semaglutide impacts the heart with new trial data available. Learn how semaglutide may reduce risks of heart attacks and also how it impacts your quality of life if you have heart failure.

Dr. Andrea Love, a microbiome expert, joins the hosts to discuss the importance of the microbiome and debunk myths surrounding it. They delve into its impact on digestion, immunity, body weight, and metabolism. The episode also explores the factors that influence the microbiome, questions marketing claims, and emphasizes the need for reliable tests and research.

Drs. Karl and Spencer chat with Amy Goekel about her history of her eating disorder. Amy has her own podcast where she discusses it is more depth as well https://podcasts.apple.com/us/podcast/the-eating-disorder-diaries/id1666122772

Dr. Andrea Love, a cancer immunologist, joins the hosts to discuss the controversy surrounding the recent headlines about aspartame being listed as a possible carcinogen by the WHO. They explore the classifications of the International Agency for Research on Cancer, the safety of aspartame consumption, and the controversy surrounding diet soda.